24,607 Shares in Kenvue Inc. (NYSE:KVUE) Bought by Copley Financial Group Inc.

Copley Financial Group Inc. bought a new stake in shares of Kenvue Inc. (NYSE:KVUE - Free Report) during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund bought 24,607 shares of the company's stock, valued at approximately $569,000.

Several other hedge funds also recently modified their holdings of KVUE. Oddo BHF Asset Management Sas purchased a new position in Kenvue during the third quarter worth about $1,570,000. Tidal Investments LLC lifted its position in shares of Kenvue by 9.9% during the 3rd quarter. Tidal Investments LLC now owns 131,128 shares of the company's stock worth $3,033,000 after buying an additional 11,849 shares in the last quarter. Wilmington Savings Fund Society FSB purchased a new position in shares of Kenvue in the 3rd quarter worth approximately $1,057,000. Sanctuary Advisors LLC grew its holdings in shares of Kenvue by 166.3% in the third quarter. Sanctuary Advisors LLC now owns 544,890 shares of the company's stock valued at $13,121,000 after acquiring an additional 340,266 shares in the last quarter. Finally, Boyar Asset Management Inc. increased its position in shares of Kenvue by 7.2% during the third quarter. Boyar Asset Management Inc. now owns 29,171 shares of the company's stock valued at $675,000 after acquiring an additional 1,948 shares during the last quarter. Hedge funds and other institutional investors own 97.64% of the company's stock.

Analyst Ratings Changes

KVUE has been the topic of several research analyst reports. JPMorgan Chase & Co. boosted their price objective on Kenvue from $24.00 to $25.00 and gave the stock an "overweight" rating in a research report on Friday, October 11th. Barclays raised shares of Kenvue to a "hold" rating in a report on Thursday. Deutsche Bank Aktiengesellschaft lowered shares of Kenvue from a "buy" rating to a "hold" rating and reduced their price target for the company from $25.00 to $24.00 in a research report on Thursday. Royal Bank of Canada raised shares of Kenvue from a "hold" rating to a "moderate buy" rating in a research report on Monday, December 9th. Finally, Bank of America increased their target price on shares of Kenvue from $24.00 to $27.00 and gave the company a "buy" rating in a research report on Tuesday, October 22nd. One research analyst has rated the stock with a sell rating, eight have issued a hold rating and three have assigned a buy rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of "Hold" and a consensus price target of $22.64.

Kenvue Stock Performance

KVUE stock traded down $0.11 during midday trading on Friday, reaching $22.21. 9,184,286 shares of the company's stock traded hands, compared to its average volume of 17,639,725. The firm has a market capitalization of $42.58 billion, a PE ratio of 40.38, a price-to-earnings-growth ratio of 2.02 and a beta of 1.36. The company has a 50-day moving average price of $22.95 and a two-hundred day moving average price of $21.17. Kenvue Inc. has a 52 week low of $17.67 and a 52 week high of $24.46. The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.69 and a current ratio of 1.00.

Kenvue (NYSE:KVUE - Get Free Report) last announced its quarterly earnings results on Thursday, November 7th. The company reported $0.28 earnings per share for the quarter, beating the consensus estimate of $0.27 by $0.01. The company had revenue of $3.90 billion during the quarter, compared to analysts' expectations of $3.92 billion. Kenvue had a return on equity of 21.43% and a net margin of 6.88%. The firm's quarterly revenue was down .4% compared to the same quarter last year. During the same period in the previous year, the business earned $0.31 earnings per share. As a group, equities analysts anticipate that Kenvue Inc. will post 1.07 EPS for the current year.

Kenvue Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Wednesday, November 27th. Stockholders of record on Wednesday, November 13th were issued a $0.205 dividend. This represents a $0.82 dividend on an annualized basis and a dividend yield of 3.69%. The ex-dividend date was Wednesday, November 13th. Kenvue's payout ratio is 149.09%.

About Kenvue

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.